Eribulin mesylate in the treatment of metastatic breast cancer

Sarika Jain, Tessa Cigler*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Eribulin mesylate in the treatment of metastatic breast cancer'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science